Camp4 Therapeutics CAMP
NASDAQ CAMP
$4.20 -0.13 (-3.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Camp4 Therapeutics (CAMP) Capital Leases (2023 - 2025)

Updated

Camp4 Therapeutics (CAMP) posted Capital Leases of $47,000 for Q3 2025, down 46.0% from $87,000 a year earlier and down 20.3% from the prior quarter.

Analysis

Camp4 Therapeutics (CAMP) Capital Leases (2023 - 2025) Analysis & Trends

At the end of FY2024, Camp4 Therapeutics' Capital Leases came in at $70,000, down 52.7% from FY2023.

  • In prior years, Camp4 Therapeutics' Capital Leases was $148,000 in FY2023.
  • According to Business Quant data, Capital Leases for the three prior quarters was $59,000 (Q2 2025), $58,000 (Q1 2025) and $70,000 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Camp4 Therapeutics 341.83 Mn -77.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 47,000.00
Jun 30, 2025 59,000.00
Mar 31, 2025 58,000.00
Dec 31, 2024 70,000.00
Sep 30, 2024 87,000.00
Dec 31, 2023 148,000.00
API Access

Camp4 Therapeutics Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=CAMP&period=max&api_key=YOUR_API_KEY